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Middle ear cholesteatoma affected more than 5 
million people until the 80`s. Many animal models were 
used, unsuccessfully, to study an alternative therapy to 
cholesteatoma. Aim: observe the effect of the trans-retinoic 
acid in the inhibition of middle ear cholesteatomas induced by 
propylene glycol. Study Design: Clinical and Experimental. 
Methods: 25 guinea pigs were submitted to the application 
of a 100% propylene glycol solution in their bulla bilaterally 
and a solution of trans-retinoic acid was applied locally in 
the external right ear, while in the left ear saline solution was 
applied (control ear). The guinea pigs were slaughtered and 
their temporal bones were prepared for macroscopic and 
histological analysis. Results: The macroscopic findings had 
evidenced the presence of cholesteatoma in 25% of the right 
ears and 85% of the left ears (P=0.0003 *). The histological 
study had evidenced the presence of cholesteatoma in 30% of 
right ears and 75% of the left ears (P=0.0104*). Conclusion: 
The local use of the trans-retinoic acid is effective in inhibiting 
the induced formation of cholesteatomas in guinea pigs. 
Keywords: guinea pig, middle ear cholesteatoma, prevention 
and control, chemically induced, chemoterapy.
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INTRODUCTION
Cholesteatomatous chronic otitis media affected an 
estimated over 5 million people worldwide in the 1980s.1 
Cholesteatomas can migrate into and invade adjacent 
structures, resulting in bone erosion and destruction of the 
middle ear ossicles. Furthermore, the disease may relapse, 
and some patients require repeated surgery. Until the pre-
sent there is no effective method to avoid cholesteatoma 
proliferation, invasion or recurrence.
Placing a mixture of talcum powder and fibrin in 
the bulla of guinea-pigs results in a typical cholesteatoma 
that originates from epidermal basal cells of the tympa-
nic membrane and migrates into the middle ear, which 
corroborates the epithelial migration theory.2 Propylene 
glycol (PG) has been shown to cause epithelial migration 
and cholesteatomatous chronic otitis media in North-
American chinchillas, in which optic drops (Cortisporin) 
containing PG (10%) was used.3 Increasing the dose of PG 
in topical preparations injected transtympanically yields 
cholesteatomas4,5 in a progressively higher percentage 
of rats, reaching 100% at a concentration of 90%. After 
producing a cholesteatoma in chinchillas by using PG 
(60%), 5-fluorouracil was used to inhibit growth of the 
cholesteatoma, with satisfactory results.6 Hyaluronic acid 
was applied to the external ear of chinchillas in an attempt 
to inhibit PG-induced cholesteatoma development, with 
poor results.7 Similarly poor results were seen when using 
cyclophosphamide systemically in chinchillas.8
Retinoic acid appears to affect epidermal keratiniza-
tion and secretory gland activity. Isotretinoin, a synthetic 
retinol analogue, was used systemically with poor choles-
teatoma-inhibiting results.9 All-trans retinoic acid is used 
topically to treat acne vulgaris. It decreases epithelial cell 
adhesion and is effective in skin keratinization disorders; it 
also helps repair skin following exposure to phototherapy 
or other external agents. All-trans retinoic acid inhibited in 
vitro cholesteatoma migration in surgically removed human 
cholesteatomas kept in a growth-promoting culture.10 
Considering that the cholesteatoma is a disease 
with multiple factors, that there are many theories about 
its etiology and pathogenesis, and that there is as yet no 
effective treatment for preventing epithelial migration and 
cholesteatoma formation in the middle ear, additional ex-
perimental studies are required to clarify these issues. The 
aim of this paper was to investigate the effects of all-trans 
retinoic acid used topically in guinea-pig external ears and 
the area adjacent to the tympanic membrane in inhibiting 
middle ear cholesteatoma formation by PG 100%.
MATERIAL AND METHOD
Twenty-five male and female guinea pigs weighing 
between 400 and 600 grams, aged between 4 and 6 mon-
ths, with no infection or history of disease, were used. 
The animals were provided by the Experimental Model 
Development Center for Medicine and Biology (Centro de 
Desenvolvimento de Modelos Experimentais para Medicina 
e Biologia). Animal rights laws defining the guidelines 
scientific experimentation and animal vivisections were 
followed; the Research Ethics Committee of the institution 
approved the study (process number 1199/02).
The animals were anesthetized with a ketamine 
chloridrate (70mg/kg) and xylazine chloridrate (6mg/kg) 
solution for intraperitoneal use. The external acoustic 
meatus or auditory canal was inspected microscopically 
to visualize the tympanic membrane and to remove wax 
and any skin desquamation. Using aseptic techniques, the 
following procedure was applied to both ears:
1. a retro-auricular incision was made, followed by 
identification of the mastoid bulla;
2. the upper portion of the bulla was opened with 
a 2mm cutting burr;
3. 0.2 ml of propylene glycol 100% was applied 
using a 25x7 needle on a 1 ml syringe;
4. the skin was closed with Nylon 4-0 sutures;
5. the acoustic canal was inspected with the surgi-
cal microscope to identify the tympanic membrane and 
retro-tympanic fluid.
The right ear was used as the experiment group 
and the left ear was used as the control group. Immedia-
tely following surgery, 0.3 ml of a 25μmol/liter all-trans 
retinoic acid aqueous solution (0.225g in 20ml solution), 
equivalent to 4,200 international units (UI/ml), was applied 
topically with a 1ml syringe in the acoustic canal to cover 
completely the right tympanic membrane. Saline (NaCl 
0.9%) was similarly applied in the left acoustic canal of 
the same animal.
Topical solutions (all-trans retinoic acid to the right 
and saline to the left) were applied a second time 48 hours 
after surgery and subsequently every 48 hours until com-
pleting five applications. The animals were contained for 
2 minutes during each topical application in both ears to 
increase the contact between the solution and the tympanic 
membrane and acoustic canal.
The guinea pigs were sacrificed six weeks after the 
first procedure; this was done by deep anesthesia with 
ketamine chloridrate (100mg/kg) and xylazine chloridrate 
(15mg/kg). The tympanic membrane was inspected and 
the temporal bones were removed (Figure 1). A small 
opening was made in the bulla if the surgical access route 
was not identified, for best bone fixation.
Each temporal bone was placed in a 10% formal-
dehyde solution and kept for three weeks for adequate 
fixation. After fixation, the bones were kept for two weeks 
in a buffered 12.5% formic acid solution for decalcification. 
Three millimeter cross-sections of the bones were made 
parallel to the tympanic membrane to obtain two equally 
sized specimens for each temporal bone; these were iden-
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(involving part of the acoustic canal, tympanic membrane 
and part of the middle ear) was chosen from each paraffin 
block. These sections were placed on slides totaling 40 
hematoxylin-eosin stained slides from each paraffin block. 
An expert pathologist analyzed histologically all of the 
slides; this pathologist did not know which were right or 
left ears or controls.
The histological definition cholesteatoma was the 
presence of a tumor consisting of non-nucleated keratin 
scales, and a corneal layer was composed of a stratified 
squamous epithelium (Figures 4 and 5).
Figure 1. Right temporal bone - note the bulla and the acoustic ca-
nal.
Figure 2. Temporal bone after decalcification and a cross-section - Ch 
- presence of cholesteatoma (defined macroscopically).
Figure 3. Temporal bone após descalcificação e corte transversal - TM: 
tympanic membrane. Note the middle ear with no macroscopically 
observable cholesteatoma.
tified as right ear and left ear and section number 1 (late-
ral, including the bony portion of the acoustic canal and 
the tympanic membrane) and section number 2 (medial, 
including the middle ear cavity and the remaining bulla). 
The sections were analyzed with a surgical microscope at 
16 times and 25 times magnification to identify tympanic 
membrane (TM) and middle ear (ME) changes. Choleste-
atomas were defined macroscopically as the presence of 
a well-organized whitish tumor in the middle ear (Figure 
2); possible cholesteatomas were defined as similar but 
dispersed and suspect areas; no evidence of cholesteato-
mas was the absence of these changes (Figure 3). Each 
lateral section, which contained the tympanic membrane 
and part of the middle ear, was dehydrated and placed in 
a paraffin block. The next step was to make microtome 
3μm cross-sections from which a representative section 
Figure 4. Cholesteatoma cyst in the middle ear (100 X magnification) 
- note the presence of keratin lamellae within the cholesteatoma 
matrix.
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Fisher’s test was used for analyzing the otoscopic 
changes seen by using the surgical microscope in relation 
to each ear. The significance level was 5%.
Fisher’s test was also used to analyze the macros-
copic findings in specimen temporal bones following its 
sectioning into two parts. The significance level was 5%.
Fisher’s test was used for analyzing the histological 
findings in right and left temporal bones of 20 guinea pigs 
in relation to the presence or absence of cholesteatomas. 
The significance level was 5%.
RESULTS
Six weeks after applying PG, there remained 20 out 
of 25 guinea pigs. Two died in the first 24 hours probably 
due to anesthesia-related problems; the other three died 
within three weeks probably due to infection. Otoscopy 
findings are presented on Table 1.
Statistical analysis (Fisher’s test) of the data shown 
on Table 1 revealed no difference between right and left 
ears.
Tables 2 and 3 show the findings according to the 
presence of cholesteatoma, possible cholesteatoma and 
no evidence of cholesteatoma.
There was a statistically significant difference 
(P=0.0003) between both groups in the distribution of 
“cholesteatoma” and “possible cholesteatoma” findings 
compared to the finding “no evidence of cholesteatoma” 
between right ears (experiment) and left ears (controls). 
The control group had significantly more suspected fin-
dings and/or findings of cholesteatomas compared to the 
experiment or study group.
Histological findings of the temporal bones of 20 
guinea pigs were divided into two groups, as follows: one 
group in which histological criteria of cholesteatomas were 
found, and a second group in which these histological 
criteria were not found (Figure 6). Table 4 shows the 
histological results divided into presence and absence of 
cholesteatomas for each ear.
Fisher’s test revealed that the right ear had sig-
nificantly less cholesteatomas compared to the left ear 
(control).
DISCUSSION
We chose guinea pigs as an experimental model 
because of the characteristics of their middle ear, which 
are similar to those of man. Furthermore, the guinea-pig 
acoustic canal allows easier inspection and handling 
such as applying topical substances, which was our case. 
The bulla is a wide cavity; the tympanic membrane and 
a non-pneumatic mastoid process form its lateral wall, 
while its medial wall is formed by most of the middle ear 
structures including the ossicles, the cochlea, the cochlear 
and vestibular windows and the semicircular canals.11 
PG was applied through an access route in the bulla to 
cause inflammation in the middle ear without handling 
the tympanic membrane. We wished to analyze the effects 
of inflammation on the tympanic membrane, especially 
on epithelial migration. As shown on Table 1, seven 
ears developed tympanic membrane perforation, while 
17 others presented opacity, six developed hyperemia, 
three developed tympanic membrane retraction and four 
presented a white retrotympanic tumor (cholesteatoma?). 
Thus, only three of 40 ears remained normal at the end 
of the experiment, showing that inflammation caused by 
PG was significant in most cases.
The most frequent findings were tympanic membra-
ne opacity and the presence of wax. Wax was most evident 
in the experiment or study ears (right ears), compared to 
the control ears (left ears). An explanation might be that 
all-trans retinoic acid at the concentration we used appears 
to favor wax formation, which was seen immediately after 
the last application of the substance, differently from the 
ears that received saline.
PG was recognized as an irritating factor for the mi-
ddle ear and a possible inducer of cholesteatoma based on 
observations of optic Cortisporin use, which was a solution 
that contained PG (10.5%).3 Cholesteatoma formation due 
to PG appears to be dose dependent.4,12 In our study we 
used PG (100%) to induce cholesteatoma formation in the 
middle ears of as many animals as possible. We wished 
to observe and compare whether all-trans retinoic acid, 
at the chosen concentration and treatment route, would 
effectively inhibit epithelial migration and, therefore, the 
development of cholesteatomas.
Is time between PG application and animal sacrifi-
ce an important factor in cholesteatoma formation? Some 
papers have shown variations in histological changes and 
cholesteatoma formation in groups of animals sacrificed 
Figure 5. Histological section of a middle ear cholesteatoma (100X 
magnification) - EE: Epitélio estratificado K: Presence of keratin la-
mellae.
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Table 1. Otoscopic findings in 20 guinea pigs at the end of the experiment according to each ear.
Findings
Ears 
    Right         Left Total 
N % N % N %
TM opacity    7 22,59 10 34,48 17 28,33
TM perforation    4 12,90 3 10,34 7 11,67
Acoustic canal secretion    5 16,13 2 6,90 7 11,67
Wax 9 29,04 5 17,25 14 23,33
Acoustic canal polyp    0 0 1 3,44 1 1,67
White retrotympanic tumor (cholesteatoma?)     0 0 4 13,79 4 6,66
Acoustic canal stenosis    1 3,22 0 0 1 1,67
TM hyperemia    4 12,90 2 6,90 6 10,00
TM retraction    1 3,22 2 6,90 3 5,00
Total 31 100,00 29 100,00 60 100,00
Key: N = number Test: Fisher’s test. NS: Not Significant. TM: tympanic membrane
Table 2. Temporal bone findings on surgical microscopy in 20 guinea-pigs according to each ear.
Findings
Ears 
    Right         Left Total 
N % N % N %
No evidence of cholesteatoma     15 75,0 3 15,0 18 45,0
Possible cholesteatoma     2 10,0 2 10,0 4 10,0
Cholesteatoma 3 15,0 15 75,0 18 45,0
Total 20 100,0 20 100,0 40 100,0
Key: N = number
Table 3. Temporal bone findings on surgical microscopy in 20 guinea-pigs according to each ear after grouping. 
Findings
Ears 
    Right         Left Total 
N % N % N %
No evidence of cholesteatoma 15 75,0 3 15,0 18 45,0
Possible cholesteatoma + Cholesteatoma      5 25,0 17 85,0 22 55,0
Total 20 100,0 20 100,0 40 100,0
Key: N = number Test: Fisher’s test P= 0.0003 *
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after different intervals. On the third week proliferation 
of the tympanic membrane epidermal basal layer begins, 
including papillary growth.5,12 On the sixth week the rate 
of PG (90%)-induced cholesteatoma reaches 87.5%.4 A 
single application of PG (50%) on the bulla of chinchillas 
was enough to show evidence of cholesteatoma formation 
on the third week.3 The time, therefore, between applying 
the mucosal irritant and sacrificing the animal is important 
for cholesteatoma formation; from the third week onwar-
ds epithelial migration and a typical cholesteatoma have 
been formed, in most papers. The moment for analyzing 
the specimens histologically varied according to different 
authors and cholesteatoma-inducing techniques; we chose 
six weeks, similar to some other authors, as we believe 
that this period is sufficient for a cholesteatoma to form. 
A longer period before histological analysis increases the 
morbidity and mortality of the specimens due to complica-
tions of the cholesteatoma itself or associated infections.
The pathogenesis of acquired cholesteatoma is ba-
sed mainly on metaplasia or migration. This, in turn, may 
be subdivided into three categories, as follows: migration 
through a tympanic membrane perforation; invagination, 
characterized by progressive tympanic membrane inva-
gination; and papillary growth, in which the epidermal 
layer of the tympanic membrane grows into the middle 
ear.13 Theses description have also been published by 
other authors.3,14 
The tympanic membrane alterations we found in 
40 ears (control and experiment groups) included visible 
retro-tympanic cholesteatomas in four ears, of which two 
presented retraction, and tympanic membrane perforation 
in seven ears. We were able, therefore, to observe cho-
lesteatoma formation in retracted, intact and perforated 
tympanic membranes; perforation might be secondary to 
necrosis, itself resulting from inflammation caused by the 
middle ear mucosa-irritating agent.
Table 1 summarizes the otoscopic findings at the 
end of the experiment, demonstrating that there were more 
visible retro-tympanic cholesteatomas in the control group, 
although this difference was not statistically significant. 
Otoscopy of the control group revealed tympanic perfora-
tion in three ears, and tympanic membrane retraction was 
observed in two ears (Table 1). Macroscopy of temporal 
bone section revealed cholesteatomas in 17 ears. Most of 
the cholesteatomas formed regardless of any tympanic 
membrane perforation or retraction; if retraction was pre-
sent in the control ears, however, a cholesteatoma was 
more easily seen otoscopically. The fact that most of the 
ears that developed cholesteatomas in the control group 
did not present tympanic membrane perforation streng-
thens the epithelial migration theory. We believe that tym-
panic membrane epidermal layer basal cell proliferation is 
an initiating factor for cholesteatoma formation.
Various papers reported unsuccessful attempts to 
inhibit cholesteatoma formation, the so-called “prophylac-
tic therapy” of cholesteatoma.8,9 There are a number of 
possible explanations for these findings, such as the use 
of a vitamin A analogue. One possibility is that isotreti-
noin treatment was done prior to the use of an irritating 
agent; findings might have been different if both agents 
had been used simultaneously. A second possibility is 
that the drug was used systemically; if it had been used 
topically, it might have more effectively inhibited epithelial 
migration. Another possibility is that isotretinoin is not 
effective against migration at the dose that was used, or 
even regardless of the dose.
Hyaluronic acid7 has been used topically to inhibit 
Table 4. Temporal bone histological findings in 20 guinea-pigs according to each ear. 
Findings
Ears 
    Right         Left Total 
N % N % N %
Absence of cholesteatoma 14 70,0 5 25,0 19 47,5
Presence of cholesteatoma 6 30,0 15 75,0 21 52,5
Total 20 100,0 20 100,0 40 100,0
Key: N = number Teste: Fisher’s test P= 0.0104*
Figure 6. Histological section of the normal middle ear epithelium (400X 
magnification) - CE: ciliated cylindrical epithelium.
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PG-induced cholesteatoma formation in chinchillas; in this 
study, cholesteatomas were found in 70% of the ears trea-
ted with hyaluronic acid and in 71% of the untreated ears. 
Extracellular calcium appears to be an important factor 
both for cell migration and adhesion in cholesteatomas. If 
calcium is removed from cholesteatoma growth and migra-
tion stimulating culture media, there is a tenfold reduction 
in the degree of cholesteatoma migration.15 Calcium is 
essential for cell to cell adhesion, for instance, between 
keratinocytes and substrate cells. These authors studied 
the in vitro inhibitory effects of all-trans retinoic acid on 
cholesteatoma migration in human cholesteatoma samples 
cultured in cell-growth simulating media. The maximum 
effect was six times more inhibition of migration at a higher 
concentration of all-trans retinoic acid (5 μmol/liter). It 
appears that the main effects of all-trans retinoic acid on 
cholesteatoma migration are decreased cell adhesiveness 
and cytoskeleton alterations, including altered calcium 
concentrations.10 All-trans retinoic acid is widely used in 
dermatology; its effects include reducing epithelial cell 
adhesiveness and treating skin keratinization disorders, 
including repairing skin after exposure to phototherapy 
and other external agents. It is used for the treatment of 
acne vulgaris and psoriasis, among other conditions.
An attempt to inhibit epithelial migration with all-
trans retinoic acid seemed pertinent based on the above-
mentioned findings and the lack of animal studies with an 
adequate methodology to attempt in vivo migration. The 
authors of another study that used topical vitamin A indu-
ced cholesteatoma formation by ligating the acoustic canal; 
they found no statistically significant difference between 
the vitamin A and Cortisporin (without PG) treated groups. 
A different was found when comparing the treated groups 
with controls; in this study, cholesteatoma formation in the 
treated group was 60%-65%.16 The method did not clarify 
how many substance applications were made, or whether 
the treatment lasted throughout the nine months that the 
experiment was conducted. Furthermore, it is difficult to 
apply a topical substance in a surgically closed cavity, since 
wax and debris accumulate and fibrosis sets in, all of which 
may have altered the effect of the substances. A further 
point is that the surgical procedure to ligate the acoustic 
canal may alter the effect of those tested substances on the 
various epidermal layers of the acoustic canal by altering 
its anatomy and physiology, thereby affecting the results. 
We believe, therefore, that an experimental method that 
does not alter the anatomy of the external ear, and speci-
fically the acoustic canal, would be more appropriate and 
would not interfere on the effect of cholesteatoma forma-
tion inhibiting substances. We found moderate quantities 
of wax in some ears with our method, particularly in the 
experimental or study ears. The three ears in this group 
that presented a cholesteatoma developed wax, secretion 
and tympanic membrane perforation. This may have in-
fluenced cholesteatoma formation by decreasing external 
ear ventilation and reducing the contact time between all-
trans retinoic acid and the tympanic membrane epithelial 
layer, possibly altering substance absorption.
Tables 2 and 3 present the findings “possible 
cholesteatoma”, “cholesteatoma” and “no evidence of 
cholesteatoma”, revealing that the control group had a 
significantly higher number in the cholesteatoma and pos-
sible cholesteatoma categories. Confronting these findings 
with the temporal bone histological analysis revealed that 
the macroscopic definition of cholesteatoma was well ap-
plied, as all of the temporal bones (n=18) that fit into this 
macroscopic definition also fulfilled the histological crite-
ria for cholesteatoma (presence of a stratified squamous 
epithelium covered by keratin scales). Some of the bones 
that were macroscopically classified under the category 
“no evidence of cholesteatoma” had histological features of 
cholesteatomas. The macroscopic category “no evidence of 
cholesteatoma” was seen in 18 ears, of which three were 
identified histologically as having middle ear cholesteato-
ma. Based on the definitions we used, if a cholesteatoma 
was defined macroscopically, histology confirmed its 
presence in 100% of cases, whereas if the macroscopic 
definition was “no evidence of cholesteatoma”, choleste-
atomas were found in 16.7% of cases; thus, it is important 
to compare macroscopic and histological findings. The 
remaining 83.3% of cases with no macroscopic evidence 
of cholesteatomas in fact did not show any histological 
finding on the slides. There were no histological findings 
of cholesteatomas in the group of ears macroscopically 
classified as “possible cholesteatoma” (n=4). The possibility 
of cholesteatomas was not confirmed; the finding in some 
slides of small whitish areas dispersed in the temporal 
bone (as defined macroscopically) may be inflammatory 
alteration of the middle ear.
Table 4 presents histological findings showing that 
cholesteatomas were present in 30% of the ears in the 
group treated with all-trans retinoic acid (6/20) and in 75% 
of the control ears (15/20). Statistical analysis (Fisher’s test) 
found that the presence of cholesteatomas in the group 
of ears treated with all-trans retinoic acid was significantly 
lower compared to the control ears (p=0.0104); all-trans 
retinoic acid, therefore, effectively inhibited cholesteatoma 
formation in our model.
Our findings differed from those of other authors16 
that used vitamin A topically to inhibit cholesteatoma for-
mation. We believe that this difference may be explained 
by the concentration we used, the method (as discussed 
above), and possibly by different pharmacological effects 
between retinoids.
Cholesteatoma inhibition by all-trans retinoic acid 
in out study was concordant with findings of in vitro 
inhibition by this drug.10 This particular paper funda-
mentally helped us decide in favor of all-trans retinoic 
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acid as a cholesteatoma formation inhibitor; we believe 
that the application method and the drug concentration 
were responsible for our results. Wax and/or secretion in 
some of the all-trans retinoic acid treated ears may have 
altered its local effect, which would explain the presence 
of cholesteatomas in some of the treated ears.
These comments and our results suggest that further 
studies are needed to apply these findings and others that 
might arise, such as the effect of all-trans retinoic acid on 
the keratonicyte cell structure, to investigate the use of 
this drugs on humans.
CONCLUSION
Our results allow us to conclude that topical use 
of all-trans retinoic acid applied to the acoustic canal and 
the area adjacent to the tympanic membrane is an effec-
tive inhibitor of propylene glycol-induced cholesteatoma 
formation in the middle ear of guinea pigs.
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